Becton, Dickinson and Co. | BDX - Cost Of Sales

Stock Price
210.02
Daily Change
3.51 1.70%
Monthly
3.61%
Yearly
-8.63%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $5.19B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Agilent USD 871M 28M Sep/2025
Align Technology USD 363.97M 7.48M Dec/2025
Avanos Medical USD 91.8M 8.9M Sep/2025
Baxter International USD 1.88B 66M Sep/2025
Becton, Dickinson and Co. USD 5.19B 2.32B Sep/2025
Bio-Rad Laboratories USD 306.3M 31.5M Jun/2025
Boston Scientific USD 1.84B 82M Dec/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 463M 17M Sep/2025
Dexcom USD 477.9M 9.6M Sep/2025
Edwards Lifesciences USD 345.2M 800K Sep/2025
Exact Sciences USD 266.81M 18.18M Sep/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Hologic USD 463.7M 5.1M Dec/2025
Insulet USD 196.2M 700K Sep/2025
Integra LifeSciences USD 195.07M 11.2M Sep/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
J&J USD 7.97B 689M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
Medtronic USD 3.52B 80M Sep/2025
Solventum Corp USD 963M 23M Sep/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 114.96M 138K Sep/2025
Teleflex USD 461.38M 111.57M Sep/2025
Terumo JPY 127.97B 13.47B Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025